Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NFKB2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | GIGYF1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | ELAC1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | CACFD1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | HSF2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | CHN2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | GDI1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | IL17RB | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | HNRNPA0 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | FOXS1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |